Platform Specialty Chemicals to Launch IPO

With three major acquisitions under its belt this year, Miami, Florida-based Platform Specialty Chemicals has launched a $350 million initial public offering to cover its past purchases and fund further growth.

The ipo, for which a share price has not yet been announced, will follow a $300 million offering in May of this year and a $651 million offering in October.

The Miami chemical firm's purchases during 2014 include three agrochemicals business, including Belgium's Agriphar for $300 million, Ireland-based Arysta Life Science for $3.5 billion and Chemtura AgroSolutions, a subsidiary of US chemical producer Chemtura for $1 billion.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.